Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2007-07-24
2007-07-24
Chan, Christina (Department: 1644)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C514S002600, C530S326000
Reexamination Certificate
active
10853567
ABSTRACT:
The invention is directed to a peptide comprising the amino acid sequence substantially as denoted by SEQ ID NO:1 and biologically functional homologues and derivatives thereof.
REFERENCES:
patent: 5114844 (1992-05-01), Cohen et al.
patent: 5780034 (1998-07-01), Cohen et al.
patent: 5985287 (1999-11-01), Tan et al.
patent: WO 95/25744 (1995-09-01), None
patent: WO 96/10039 (1996-04-01), None
Wright, HT, 1991, Crit Rev Biochem Mol Biol. 26:1-52.
McKerrow, JH, 1979, Mech Ageing Dev 10:371-377.
World wide web.infoplease.com/dictionary/immunity, downloaded Mar. 23, 2006, 2 pages.
World wide web.onelook.com/?other=web1931&w=Immunity, downloaded Mar. 23, 2006, one page.
Stryer, L Biochemistry, 4thedition, W.H. Freeman & Co. 1995, pp. 53-58.
“Amino Acid Side Chain Modification Agents”, downloaded from piercenet.com on Mar. 24, 2006, 2 pages.
“Protein Modification Reagents”, downloaded from piercenet.com on Mar. 24, 2006, 4 pages.
“Cross-Linking”, downloaded from piercenet.com on Mar. 24, 2006, 10 pages.
“Crosslinking Reagents”, downloaded from piercenet.com on Mar. 24, 2006, 2 pages.
The Merck Manual of Diagnosis and Therapy, 17thedition, 1999, editors Beers and Berkow, Merck Research Laboratories, pp. 96-99, 1290-1295, and 1474-1477.
Colman, P.M., 1994, Research in Immunology, 145:33-36.
Lopez-Guerrero et al., 1993, Infection and Immunity, 61:4225-4231.
The Merck Manual of Diagnosis and therapy, 17thedition, Merck Resaerch Laboratories, 1999, pp. 416-423, 922-925, and 1496-1499.
Astarloa et al., J. Neurological Sciences, 1996 135:182-183.
Xiao et al., BMC Blood Disorders, 2004, 4:1, 10 pages.
Janeway et al., Immunobiology, 3rdedition, Garland Publishing Inc, 1997, pp. 8:2-8:7.
Jordan et al., Clin exp Immunol 1994, 97 suppl 1:31-38.
Anderton et al., “Inflammation activates self hsp60-specific T. cells”, Eur. J. Immuno., 23:33-38, 1993.
Anderton et al., “Activation of T Cells Recognizing Self 60-kD Heat Shock Protein Can Protect against Experimental Arthritis”, J. Exp. Med., 181:943-952, 1995.
Anderton et al, “Differential mycobacterial 65-kDa Heat Shock Protein T. Cell Epitope Recognition after Adjuvant Arthritis-Inducing or Protective Immunization Protocols”, Journal of Immunology, 152:3656-3664, 1994.
Barker et al., “Differential Effects of Immunization with Mycobacterial 65 kD Heat Shock Protein on Two Model of Autoimmunity”, Immunity, 14:73-77, 1992.
Billingham et al, “a Mycobacterial 65-kD heat Shock Protein Induces Antigen-Specific Suppression Of Adjuvant Arthritis, But Is Not Itself Artritogenic”, J. Exp. Med. 171:339-344,1990.
Chen et al., “Human 60-kDa Heat-Shock Protein: A Danger Signal to the Innate Immune System”, The Journal of Immunology, 162:3212-3219, 1999.
Elias, D. and Cohen, Ir, “The hsp60 Peptide p277 Arrests the Autoimmune Diabetes Induced by the Toxin Streptozotocin” Diabetes, 45:1168-1172, 1996.
Elais, D. and Cohen, Ir, “Peptide therapy for diabetes in NOD mice”, The Lancet, 343:704-706, 1994.
Freidland et al, “Mycobacterial 65-kD heat shcok protein induces release of proinflammatory cytokines from human monocytic cell”, Clin Exp. Immunol, 91:58-62, 1993.
Ghoraishian et al, “Comparison between the protective effects of mycobacterial 65-kD heat shock protein and ovomucoid in pristane-induced arthritis: relationship with agalactosyl lgG”, Clin. Exp. Immunol., 94:247-251, 1993.
Griffiths et al., “Induction of Autoimmune Arthritis in Rats by Immunization with Homologous Rat Type II Collagen is Restricted to the RT1av1 Haplotype”, Arthritis and Rheumatism, 36(2):254-258, 1993.
Henwood et al, “Restricted T Cell receptor expression by human T cell clones specific for mycoobacterial 65-kDa heat-shock protein: selective in vivo expansion of T cells bearing defined receptors”, Eur. J. Immunol., 23:1256-1265, 1993.
Hill Gaston et al, “Recognition of a mycobacteria-Specific Epitope in the 65 kD Heat-Shock Protein by Synovial Fluid-Derived T Cell Clones”, J. Exp. Med., 171:831-841, 1990.
Hill Gaston et al, “In Vitro Responses to a 65-Kilodatton Mycobacterial Proteins by Synovial T. Cells from Inflammatory Arthritis Patients”, The Journal of Immunology, 143(8):2494-2500, 1989.
Hogervorst et al, “Modulation of Experimental Autoimmunity: Treatment of Adjuvant Arthritis by Immunization with Recombinat Vaccinia Virus”, Infection and Immunity, 59(6):2029-2035, 1991.
Hogervorst et al., “T cell reactivity to an epitope of the mycobacterial 65-kDa heat-shock protein (hsp 65) corresponds with arthritis susceptibility in rats and is regulated by hsp 65-specific cellular responses”, J. Immunol. 21:1296, 1991.
Holoshitz et al., T Lymphocytes of Rheumatoid Arthritis Patients Show Augmented Reactivity to a Fraction of Mycobateria Cross-Reactive with Cartilage, The Lancet, 305-309, 1986.
Holoshitz et al, “Lines of T Lymphocytes Induce or Vaccinate Against Autoimmune Arthritis” Science, 219:56-58, 1983.
Jindal et al, “Primary Structure of a Human Mitochondrial Protein Homologous to the Bacterial and Plant Chaperonins and to the 65-Kilodalton mycobacterial Antigen”, Molecular and Cellular Biology, 9 (5):2279-2283, 1989.
Jordan, SC and Toyoda, M, “Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin”, Clin. Exp. Immunol., 97(1):31-38, 1994.
Kasprzyk et al, “Solid-Phase peptide Quantitation Assay Using Labeled Monoclonal Antibody and Glutaraldehyde Fixation”, Analytic Biochemistry, 174:224-234, 1988.
Kleinau et al, “A Monoclonal Antibody to the Mycobacterial 65kDa Heat Shock Protein (ML 30) Binds to Cells in Normal and Arthritic Joints of Rats”, Scand. J. Immunol., 33:195-202, 1991.
Lopez-Mortalla et al, “A common structural motif in immunopotentiating peptides with sequences present in human autoantigens. Elicitation of a response mediated by monocytes and Th 1 cells”, Biochemica et Biophysica acta, 1317:183-191, 1996.
Maloy et al, “Production of Antipeptide Antisera”, Current Protocols in Immunology, 39:9.4-9.4.12, 2000.
Margulies, DH, “Antibody Detection and Preparation”, Current Protocols in Immunology, 2.01-1.13.16, 1996.
Moudgil et al., “Diversification of T Cell Responses to Carboxy-terminal Determinants within the 65-kD Heat-Shock Protein is Involved in Regulation of Autoimmune Arthritis”, J. Exp. Med., 185(7):1307-1316, 1997.
Munk et al., “T Lymphocytes from Healthy Individuals with Specificity to Self-Epitopes Shared by the Mycobacterial And Human 65-Kilodalton Heat Shock Protein”, The Journal of Immunology, 143(9):2844-2849, 1989.
Pearson, Carl M., “Development of Arthritis, periarthritis and Perlostitis in Rats Given Adjuvants”, Proc. Soc. Exp. Biol. Med. 91:95-100 (1956).
Pearson, Carl M. and Wood, Fae D., “Studies of Polyarthritis and Other Lesions Induced in Rats by Injection of Mycobacterial Adjuvant. I. General Clinical and Pathologic Characteristics and Some Modifying Factors”, Arthritic Lesions from Mycobacteria, 2:440-450 (1956).
Prakken et al., “Nasal administration of arthritis-related T cell epitopes of heat shock protein 60 as a promising way for immunotherapy in chronic arthritis”, Biotheraphy, 10:205-211, 1998.
Prakken et al, “Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis”, Proc. Natl. Acad. Sci. USA, 94:3284-3289, 1997.
Qauyle et al, “peptide recognition, T cell receptor usage and HLA restriction elements of human heat-shcok protein (hsp) 60 and mycobacterial 65-kDa hsp-reactive T cell clones from rheumatoid synovial fluid”, Eur. J. Immunol., 22:1315-1322, 1992.
Res et al., “Synovial Fl
Kashi Yechezkel
Naparstek Yaakov
Ulmansky Rina
Bianco Paul D.
Chan Christina
Fleit Martin
Fleit Kain Gibbons Gutman Bongini & Bianco P.L.
Hadasit Medical Research Services & Development Ltd.
LandOfFree
Amino acid sequences, DNA encoding the amino acid sequences,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino acid sequences, DNA encoding the amino acid sequences,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino acid sequences, DNA encoding the amino acid sequences,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3803253